1
Corresponding Author Name:_________________
Manuscript Number:_________________
Reporting Summary
Springer Nature wishes to improve the reproducibility of the work that we publish. This checklist is used to ensure good
reporting standards and to improve the reproducibility. Please respond completely to all questions relevant to your
manuscript. For more information, please read the journal’s Guide to Authors.
Check here to confirm that the following information is available in the Material & Methods section:
The exact sample size (n) for each experimental group/condition, given as a number, not a range
A description of the sample collection allowing the reader to understand whether the samples represent
technical or biological replicates (including how many animals, litters, culture, etc.)
A statement of how many times the experiment shown was replicated in the laboratory
Definitions of statistical methods and measures: For small sample sizes (n<5) descriptive statistics are not
appropriate, instead plot individual data points
o Very common tests, such as t-test, simple χ
2
tests, Wilcoxon and Mann-Whitney tests, can be
unambiguously identified by name only, but more complex techniques should be described in the
methods section
o Are tests one-sided or two-sided?
o Are there adjustments for multiple comparisons?
o Statistical test results, e.g., P values
o Definition of ‘center values’ as median or mean;
o Definition of error bars as s.d. or s.e.m. or c.i.
Please ensure that the answers to the following questions are reported in the manuscript itself. We encourage you to
include a specific subsection in the methods section for statistics, reagents and animal models. Below, provide the
page number or section and paragraph number.
Statistics and general methods
Reported in section/paragraph or page #
1. How was the sample size chosen to ensure
adequate power to detect a pre-specified effect
size? (Give section/paragraph or page #)
For animal studies, include a statement about sample
size estimate even if no statistical methods were
used.
2. Describe inclusion/exclusion criteria if samples or
animals were excluded from the analysis. Were
the criteria pre-established? (Give
section/paragraph or page #)
3. If a method of randomization was used to
determine how samples/animals were allocated
to experimental groups and processed, describe
it. (Give section/paragraph or page #)
For animal studies, include a statement about
randomization even if no randomization was
used.
Academic Journals Reporting Checklist, November 2020
2
4. If the investigator was blinded to the group
allocation during the experiment and/or when
assessing the outcome, state the extent of
blinding. (Give section/paragraph or page #)
For animal studies, include a statement about
blinding even if no blinding was done.
5. For every figure, are statistical tests justified as
appropriate?
Do the data meet the assumptions of the tests (e.g.,
normal distribution)?
Is there an estimate of variation within each group of
data?
Is the variance similar between the groups that are
being statistically compared? (Give
section/paragraph or page #)
Reagents
Reported in section/paragraph or page #
6. Report the source of antibodies (vendor and
catalog number)
7. Identify the source of cell lines and report if they
were recently authenticated (e.g., by STR
profiling) and tested for mycoplasma
contamination
Animal Models
Reported in section/paragraph or page #
8. Report species, strain, sex and age of animals
9. For experiments involving live vertebrates,
include a statement of compliance with ethical
regulations and identify the committee(s)
approving the experiments.
10. We recommend consulting the ARRIVE guidelines (PLoS Biol. 8(6), e1000412,2010) to ensure that other
relevant aspects of animal studies are adequately reported.
Academic Journals Reporting Checklist, November 2020
3
Human subjects
Reported in section/paragraph or page #
11. Identify the committee(s) approving the study
protocol.
12. Include a statement confirming that informed
consent was obtained from all subjects.
13. For publication of patient photos, include a
statement confirming that consent to publish
was obtained.
14. Report the clinical trial registration number (at
ClinicalTrials.gov or equivalent).
15. For phase II and III randomized controlled trials, please refer to the CONSORT statement and submit the
CONSORT checklist with your submission.
16. For tumor marker prognostic studies, we recommend that you follow the REMARK reporting guidelines.
Data deposition
Reported in section/paragraph or page #
17. Provide accession codes for deposited data.
Data deposition in a public repository is
mandatory for:
a. Protein, DNA and RNA sequences
b. Macromolecular structures
c. Crystallographic data for small molecules
d. Microarray data
Deposition is strongly recommended for many other datasets for which structured public repositories exist; more
details on our data policy are available in the Guide to Authors. We encourage the provision of other source data
in supplementary information or in unstructured repositories such as Figshare and Dryad. We encourage
publication of Data Descriptors (see Scientific Data) to maximize data reuse.
18. If computer code was used to generate results
that are central to the paper’s conclusions,
include a statement in the Methods section
under “Code availability” to indicate whether
and how the code can be accessed. Include
version information as necessary and any
restrictions on availability.
Academic Journals Reporting Checklist, November 2020